Blueprint Medicines
Cheng Fang is an experienced professional with a background in computational modeling, cheminformatics, and machine learning in the pharmaceutical and biotechnology industry. Cheng has held roles such as Associate Director, Principal Scientist, and Senior Scientist II at Blueprint Medicines, specializing in cheminformatics and machine learning. With a strong educational background, including a PhD in Computational Science, Cheng has made significant contributions in drug design, lead optimization, and predictive modeling throughout various positions at companies such as Biogen, Merck, and University of Pittsburgh. Cheng's expertise also extends to computational kinetic modeling and polypharmacology analysis, showcasing a diverse skill set in the field of pharmaceutical sciences.
This person is not in any teams
Blueprint Medicines
4 followers
Blueprint Medicines Corporation is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation.